biote CorpBTMD
Price$1.21

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $183.5M-6.9% YoYTTM through 30 Jun 2026
Net Income $5.9M+85.5% YoYTTM through 30 Jun 2026
Free Cash Flow $19.9MTTM through 30 Jun 2026

Margins

Current
Gross Margin71.5%
EBITDA Margin10.1%
Operating Margin18.5%
Net Margin3.2%

Returns

-62.7%ROE
29.4%ROA
55.8%ROIC

Balance Sheet Health

Debt / Equity-2.12x
Current Ratio1.22x
Net Debt$82.9M
Cash & Equivalents$11.2M

Quality Metrics

Altman Z-Score1.90
Piotroski F-Score6 / 9
FCF Margin10.8%
Rule of 4014.7
Earnings-Beat Rate50.0%

Multi-Year Trend

Revenue
'21'22'23'24'25
FY2025: $192.2M
Diluted EPS$0.14TTM
'22'23'24'25
FY2025: $0.74

Dividend

No dividend

Capital Allocation

Capex Intensity2.4%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.